| Financial Year |
March 31 2023 |
| Monetary Funds |
938,710,015.66 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
29,878,506.15 |
| Accounts Receivable |
288,885,336.92 |
| Advances to Suppliers |
8,956,685.28 |
| Other Receivables |
3,925,828.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
415,293,748.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,312,566.94 |
| Total Current Assets |
1,709,835,191.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
4,470,201.42 |
| Fixed Assetes |
315,481,710.18 |
| Under-construction Projects |
57,194,144.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,611,827.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,692,483.48 |
| Deferred Income Tax Assets |
9,920,167.18 |
| Other Non-Current Assets |
29,043,831.15 |
| Sub-Total of Non-Current Assets |
515,624,512.32 |
| Total Assets |
2,225,459,703.63 |
| Short-Term Loans |
203,885,536.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
143,804,890.61 |
| Accounts Payable |
190,910,259.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,484,992.88 |
| Taxes Payable |
931,380.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,039,080.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,923,539.77 |
| Other Current Liabilities |
19,441,837.88 |
| Sub-Total of Current Liabilities |
689,476,603.66 |
| Long-term Loans |
94,669,193.75 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
20,579,707.43 |
| Deferred Income Tax Liabilities |
8,842,932.09 |
| Other Non-Current Liabilities |
9,843,069.95 |
| Sub-Total of Non-Current Liabilities |
161,824,023.19 |
| Total Liabilities |
851,300,626.85 |
| Paid-In Capital(Or Share Stock) |
137,169,230.00 |
| Capital Surplus |
1,009,851,645.75 |
| Surplus Reserve |
25,955,923.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
168,330,751.78 |
| Minority Stockholder's Interest |
25,201,985.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,348,957,090.95 |
| Owner's Equity（Stockholder's Equity） |
1,374,159,076.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,225,459,703.63 |
